GHP recruits new CEO for two of its clinics in Stockholm

Rein Seensalu, gastroenterologist and Associate Professor at the Karolinska
Institute, assumes the position of CEO of GHP Kirurgkliniken Stockholm and GHP
Stockholm Gastro Center on 1 June 2015. Rein’s most recent position was at
Ledningsbolaget i Skandinavien, where he was CEO.
Rein Seensalu has great experience of leadership in health care. He has formerly
held a number of senior positions, for example at Capio S:t Göran Hospital,
where he was involved in transforming the business from health care under the
auspices of the County Council into health care under private management. He has
also experience from the pharmaceuticals industry and most recently from
Ledningsbolaget, where he held the position of CEO. In this capacity he has been
the interim CEO of GHP Kirurgkliniken Stockholm since November. He therefore
knows the clinic and the employees well and has already had the opportunity of
starting interesting development projects.

“We are very pleased that Rein has chosen to become part of the GHP Group by
shouldering the role of CEO for two of our clinics in Stockholm. With his
knowledge, energy and experience of leading health care organisations, he will
be a great asset to our businesses, which have exciting development
opportunities ahead of them,” says Daniel Öhman, CEO of GHP.

GHP Stockholm Gastro Center conducts business operations within medical
gastroenterology and endoscopy. GHP Kirurgkliniken Stockholm carries out obesity
surgery and general surgery within the fields of proctology, the gall bladder
and hernia. Both clinics are situated at Sophiahemmet and GHP Gastro Center
Stockholm is also located in premises at Odenplan.

11 May 2015
Gothenburg, Sweden
Global Health Partner AB (publ)
Queries should be addressed to:
Daniel Öhman, CEO, Tel: +46 (0) 708 55 37 07
Tobias Linebäck, CFO and Head of Investor Relations, Tel: +46 (0) 708 55 37 19
GHP is an internationally active health care provider that operates specialist
clinics in a select number of diagnostic areas through the application of a
business model that is unique in the health care industry, where leading doctors
become partners and shareholders. Multiple clinics with high patient volumes
within the same diagnostic area produce increased efficiency and higher quality,
which is the cornerstone of GHP's business philosophy – “Quality through
specialisation”. GHP shares are traded on the Small Cap list of Nasdaq Stockholm
under the ticker symbol “GHP”.

Global Health Partner AB (publ) | Corp. ID No. 556757-1103
Södra Hamngatan 45 | SE-411 06 Gothenburg | Sweden
Tel +46-31 712 53 00 | Fax +46-31 313 13 21 | www.ghp.se

Global Health Partner AB is required to publish the information herein according
to the Swedish Securities Market Act. This information was published on 11
May 2015 at 2:00 p.m. CET.

This is a translation of the Swedish version of the press release. When in
doubt, the Swedish wording prevails.